{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:22:54Z","timestamp":1790043774660,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.bcmd.2009.03.006","type":"journal-article","created":{"date-parts":[[2009,4,20]],"date-time":"2009-04-20T04:46:46Z","timestamp":1240202806000},"page":"134-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impaired IL-10 transcription and release in animal models of Gaucher disease macrophages"],"prefix":"10.1016","volume":"43","author":[{"given":"Yaacov","family":"Kacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony H.","family":"Futerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2009.03.006_bib1","series-title":"Gaucher Disease","author":"Futerman","year":"2006"},{"key":"10.1016\/j.bcmd.2009.03.006_bib2","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.bcmd.2009.03.006_bib3","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1016\/j.febslet.2006.08.041","article-title":"Genetic diseases of sphingolipid metabolism: pathological mechanisms and therapeutic options","volume":"580","author":"Kacher","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcmd.2009.03.006_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","article-title":"Gaucher disease: pathological mechanisms and modern management","volume":"129","author":"Jmoudiak","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2009.03.006_bib5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"Futerman","year":"2004","journal-title":"Nat. Rev., Mol. Cell Biol."},{"key":"10.1016\/j.bcmd.2009.03.006_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-007-0296-4","article-title":"Immune system irregularities in lysosomal storage disorders","volume":"115","author":"Castaneda","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bcmd.2009.03.006_bib7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/brain\/awg089","article-title":"Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis","volume":"126","author":"Jeyakumar","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.bcmd.2009.03.006_bib8","first-page":"205","article-title":"Cytokines in Gaucher's disease","volume":"10","author":"Barak","year":"1999","journal-title":"Eur. Cytokine Network"},{"key":"10.1016\/j.bcmd.2009.03.006_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/bcmd.1997.0137","article-title":"Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease","volume":"23","author":"Hollak","year":"1997","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2009.03.006_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10","volume":"90","author":"Allen","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.bcmd.2009.03.006_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/bcmd.1997.0156","article-title":"Cytokine mRNA in Gaucher disease","volume":"23","author":"Lichtenstein","year":"1997","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2009.03.006_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2009.03.006_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0003-9861(88)90467-5","article-title":"Active site directed inhibition of a cytosolic beta-glucosidase from calf liver by bromoconduritol B epoxide and bromoconduritol F","volume":"260","author":"Legler","year":"1988","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcmd.2009.03.006_bib14","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI0214530","article-title":"Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage","volume":"109","author":"Mizukami","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2009.03.006_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2990.2003.00455.x","article-title":"Reduced rates of axonal and dendritic growth in embryonic hippocampal neurones cultured from a mouse model of Sandhoff disease","volume":"29","author":"Pelled","year":"2003","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bcmd.2009.03.006_bib16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng1095-170","article-title":"Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism","volume":"11","author":"Sango","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2009.03.006_bib17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2013dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bcmd.2009.03.006_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0014-4800(88)90068-8","article-title":"Macrophages exposed in vitro to conduritol B epoxide resemble Gaucher cells","volume":"48","author":"Newburg","year":"1988","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bcmd.2009.03.006_bib19","first-page":"416","article-title":"Gaucher-like changes in human blood-derived macrophages induced by beta-glucocerebrosidase inhibition","volume":"111","author":"Yatziv","year":"1988","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.bcmd.2009.03.006_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bcmd.2004.03.001","article-title":"Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes","volume":"33","author":"Trajkovic-Bodennec","year":"2004","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2009.03.006_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bcmd.2007.03.005","article-title":"Changes in macrophage morphology in a Gaucher disease model are dependent on CTP:phosphocholine cytidylyltransferase alpha","volume":"39","author":"Kacher","year":"2007","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2009.03.006_bib22","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.95.5.2503","article-title":"Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure","volume":"95","author":"Liu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2009.03.006_bib23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.intimp.2004.01.007","article-title":"Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization","volume":"4","author":"Nagalakshmi","year":"2004","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcmd.2009.03.006_bib24","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages","volume":"147","author":"Fiorentino","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcmd.2009.03.006_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis","volume":"75","author":"Kuhn","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2009.03.006_bib26","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1172\/JCI118290","article-title":"Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance","volume":"96","author":"Berg","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2009.03.006_bib27","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.4049\/jimmunol.158.8.3971","article-title":"Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration","volume":"158","author":"Pajkrt","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcmd.2009.03.006_bib28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1084\/jem.177.2.547","article-title":"Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia","volume":"177","author":"Gerard","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2009.03.006_bib29","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.177.4.1205","article-title":"Interleukin 10 protects mice from lethal endotoxemia","volume":"177","author":"Howard","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2009.03.006_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cellimm.2007.01.008","article-title":"Dissecting the cytokine network","volume":"244","author":"Muller","year":"2006","journal-title":"Cell Immunol."},{"key":"10.1016\/j.bcmd.2009.03.006_bib31","first-page":"411","article-title":"Macrophage TNF mRNA expression induced by LPS is regulated by sphingomyelin metabolites","volume":"11","author":"Lo","year":"1999","journal-title":"Shock"},{"key":"10.1016\/j.bcmd.2009.03.006_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jcp.21101","article-title":"Ceramide inhibits LPS-induced production of IL-5, IL-10, and IL-13 from mast cells","volume":"213","author":"Chiba","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcmd.2009.03.006_bib33","article-title":"A ceramide-1-phosphate analogue, PCERA-1, simultaneously suppresses tumour necrosis factor-alpha and induces interleukin-10 production in activated macrophages","author":"Goldsmith","year":"2008","journal-title":"Immunology"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979609000643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979609000643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:25:26Z","timestamp":1761049526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979609000643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1079979609000643"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2009.03.006","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired IL-10 transcription and release in animal models of Gaucher disease macrophages","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2009.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}